IMAGING THE FUTURE OF THERAPEUTICS Trademark

Trademark Overview

On Thursday, August 26, 2010, a trademark application was filed for IMAGING THE FUTURE OF THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the IMAGING THE FUTURE OF THERAPEUTICS trademark a serial number of 85116562. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, September 2, 2020. This trademark is owned by BioLaurus Inc.. The IMAGING THE FUTURE OF THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Laboratory research in the field of medical drug and device development; consulting services for preclinical medical drug and device development
imaging the future of therapeutics

General Information

Serial Number85116562
Word MarkIMAGING THE FUTURE OF THERAPEUTICS
Filing DateThursday, August 26, 2010
Status800 - REGISTERED AND RENEWED
Status DateWednesday, September 2, 2020
Registration Number3947872
Registration DateTuesday, April 19, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 1, 2011

Trademark Statements

Goods and ServicesLaboratory research in the field of medical drug and device development; consulting services for preclinical medical drug and device development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 31, 2010
Primary Code042
First Use Anywhere DateWednesday, September 9, 2009
First Use In Commerce DateWednesday, September 9, 2009

Trademark Owner History

Party NameBioLaurus Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92106
Party NameBioLaurus Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92166
Party NameBioLaurus Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92166

Trademark Events

Event DateEvent Description
Wednesday, September 2, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, September 2, 2020REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, September 2, 2020REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, September 1, 2020TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Monday, August 31, 2020POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Sunday, August 30, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, July 21, 2020TEAS SECTION 8 & 9 RECEIVED
Sunday, April 19, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, April 28, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, April 28, 2017REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, April 28, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, March 9, 2017TEAS SECTION 8 & 15 RECEIVED
Tuesday, April 19, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, February 1, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 1, 2011PUBLISHED FOR OPPOSITION
Wednesday, December 29, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 29, 2010ASSIGNED TO LIE
Monday, December 6, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 6, 2010EXAMINER'S AMENDMENT ENTERED
Monday, December 6, 2010NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, December 6, 2010EXAMINERS AMENDMENT E-MAILED
Monday, December 6, 2010EXAMINERS AMENDMENT -WRITTEN
Monday, December 6, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 6, 2010NON-FINAL ACTION E-MAILED
Monday, December 6, 2010NON-FINAL ACTION WRITTEN
Friday, December 3, 2010ASSIGNED TO EXAMINER
Tuesday, August 31, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 30, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

therapeutics future imaging device development medical drug services preclinical consulting research field laboratory